Cannabis Based Healing Products Lead Commercialization For Medical Marijuana Patients - Company Introduces New Edible CBD-Rich Product Line
CORAL SPRINGS, Florida, July 16, 2014 /PRNewswire/ --
Cannabis & Pharmaceutical companies announce progress on product development and display a promise for growth as industry matures: Novagant Corp. (OTC: NVGT), GreenGro Technologies, Inc. (OTC: GRNH), Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), American Green, Inc. (OTC: ERBB) and Creative Edge Nutrition, Inc. (OTC: FITX)
Novagant Corp. (OTC Pink: NVGT) is pleased to announce that in this month of July it will release its GoldenCBD™ oil that will be available in several forms, including capsules and liquids. It will be the answer for those Medical Cannabis Patients living outside Washington and Colorado. Novagant's GoldenCBD™, along with its GLAVAPE™ product, is proud to be the finest, most consistent Cannabidiol (CBD)-rich hemp oil in the world. The Company combined the power of natural hemp with the gift from mother nature to scientifically formulated CBD-rich hemp oil.
GoldenCBD™ is 100% natural and derived from the federally-legal industrial hemp plant. The Company's unique hemp cultivars, combined with its proprietary technologies, produce the highest quality CBD-rich hemp oil in the world. GoldenCBD" is a mark of quality ensuring the highest quality as it is lab tested multiple times during the manufacturing process, from seed to shelf. The Company tests for CBD content, other cannabinoid content, yeast/mold/fungus, and bacteria like E. coli to ensure safety and quality.
Read the FULL NVGT Press Release at http://www.fnmprofiles.com/profiles-nvgt.html
Novagant, Inc. updated its shareholders and supporters this week that it is aggressively in the process of expanding its Cannabidiol (CBD) product line as a follow-up to its recent announcements of its GLAVAPE™ (Generally Legal American Vape) medical cannabis vaporizer product based on CBD-rich hemp oil and of its newly launched E-Commerce portal website for its new GLAVAPE™ product at www.glavape.com.
The company has been developing its legal hemp product line and marketing strategies for its points of entry for retail sales to take advantage of a potential $8.4 billion medical cannabis industry. "We at the Company have been busy developing our hemp oil product line of which the GLAVAPE™ was our first to be introduced," says Michael Thornton, Novagant's Vice-President. "Please stay tuned for further announcements on our product development and marketing."
GreenGro Technologies, Inc. (OTC Pink: GRNH) recently provided an update for progress made on both BP Gardens Projects. The long awaited BP gardens Buena Park will begin full production and BP Gardens Lincoln is simultaneously coming online. The company has all of the infrastructure in place in Lincoln Hills to begin a first phase of a full grow cycle production September 1. This test run will utilize approximately half of the total greenhouse capacity with the remaining space coming online after an initial 60 day trial period. Another distinct advantage of Lincoln is the existence of onsite wells and a natural underground spring that will supply water for the project year round. As part of the agreement with the land owner the company has secured exclusive water rights. This underground natural spring will form the bases of the projects fishery and full aquaponics grow systems.
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced that it was granted U.S. Patent No. 8,778,950, entitled "Cannabinoid Receptor Modulators," by the United States Patent and Trademark Office for APD371, an agonist of the cannabinoid receptor 2 (CB2). Arena is exploring several potential indications for APD371, including chronic pain, and is currently conducting a Phase 1 single-ascending dose trial. "Intellectual property protection is an important element of our clinical-stage pipeline," said Jack Lief, Arena's President and Chief Executive Officer. "This patent provides us further confidence that APD371 can be exclusive to Arena until at least 2030."
American Green, Inc. (OTC Pink: ERBB) recently announced that it has sold all of the assets of its wholly owned subsidiaries OneBode Holdings LLC and OneBode Ventures LLC for $3,500,000 to the Healthy Home Company and OneBode founders Sean and Tylene Loomer. OneBode was acquired by American Green in June of 2013. The sales price reflects the value created in OneBode over the past year and locks in a solid rate of return for American Green shareholders. Simultaneously it will free both time and operating capital for American Green to focus on its other divisions as it expands and utilizes the offices formerly occupied by OneBode. "Healthy Home is a rapidly growing business with a unique sales model that doesn't require physical locations or cyber marketing. Rewarding people for telling others about their products is the oldest and most powerful form of advertising. This model is perfectly suited to get the OneBode products to the people that need them," comments Stephen Shearin, American Green President. "This is absolutely the best outcome for all parties involved and while we'll miss the OneBode team and its enthusiasm, this will enable them to flourish in an organization perfectly suited to their endeavors."
Creative Edge Nutrition, Inc. (OTC Pink: FITX) recently announced the appointment of Mr. Keith William Volpone, Mr. Eric Nashman and Dr. Roger Shaban to its Board of Directors. "We are excited to welcome Mr. Volpone, Mr. Nashman and Dr Shaban to our team," stated Bill Chaaban, President & CEO. "It is our focus as a company to continue to bolster our board of directors to reflect the world-class talent to strengthen our partnerships and build value for our shareholders. Keith, Eric and Roger bring a diverse wealth of knowledge and experience to our team that will assist in the build out of technology integrations, new commerce pathways and thoughtful consumer experiences that support and an enhance our medical research, manufacturing and product development initiatives."
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit http://www.financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.financialnewsmedia.com/. Follow us on Facebook: http://www.facebook.com/financialnewsmedia and Twitter: http://twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated one thousand four hundred dollars for news coverage of the current press release issued by Novagant Corp. by a non-affiliated third party company.
FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
SOURCE FN Media Group, LLC